CLINICAL EVALUATION OF MESORIDAZINE IN MENTALLY RETARDED PATIENTS

被引：6
作者：
ZALESKI, WA [1 ]
机构：
[1] SASKATCHEWAN TRAINING SCH,MOOSE JAW,SASKATCHEWAN,CANADA
来源：
CANADIAN PSYCHIATRIC ASSOCIATION JOURNAL | 1970年 / 15卷 / 03期
关键词：
D O I：
10.1177/070674377001500316
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：319 / 322
页数：4
相关论文
共 11 条
  • [1] AST H, 1967, CURR THER RES CLIN E, V9, P623
  • [2] BALDWIN RW, 1967, CURR THER RES CLIN E, V9, P457
  • [3] DESILVERIO RV, 1968, J CLIN PHARMACOL N D, V8, P60
  • [4] DOUGLAS KW, 1967, DIS NERV SYST, V28, P113
  • [5] GALLANT DM, 1965, CURR THER RES CLIN E, V7, P102
  • [6] GOLDSTEIN BJ, 1967, CURR THER RES CLIN E, V9, P256
  • [7] LOWENSTAM I, 1967, J CLIN PHARMACOL N D, V7, P111
  • [8] A STUDY OF THIORIDAZINE AND ITS SIDE-CHAIN DERIVATIVE MESORIDAZINE IN CHRONIC MALE HOSPITALIZED PSYCHIATRIC PATIENTS
    MENA, A
    GRAYSON, H
    COHEN, S
    [J]. JOURNAL OF NEW DRUGS, 1966, 6 (06): : 345 - &
  • [9] PRUSMACK JJ, 1966, J NEW DRUGS, V6, P182
  • [10] RUDY L, 1968, DIS NERV SYST, V29, P412
12